Skip to main content
Log in

Wichtiges zur Therapie vor, während und nach der Schwangerschaft

Rheumakranke Frauen: Kinderwunsch ist heutzutage meist erfüllbar

  • Fortbildung
  • Published:
Orthopädie & Rheuma Aims and scope

Viele entzündliche Rheumaerkrankungen kommen bei Frauen häufiger vor als bei Männern. Manche dieser Erkrankungen beginnen oft im sogenannten gebärfähigen Alter. Dazu zählen unter anderen die rheumatoide Arthritis und der systemische Lupus erythematodes oder das axiale Befallsmuster der Spondyloarthritis. Modernen Therapieoptionen ist es zu verdanken, dass eine entzündlich rheumatische Erkrankung einer Frau heutzutage dem Wusch nach Kindern nicht mehr entgegensteht.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Chakravarty E, Clowse ME, Pushparajah DS, Mertens S, Gordon C. Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives. BMJ Open 2014;4:1–10

    Article  Google Scholar 

  2. Skorpen CG, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016;75:795–810

    Article  CAS  Google Scholar 

  3. Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L, Mestanza-Peralta M, Lara-Reyes P, Seuc AH et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 2005;353:2539–49

    Article  CAS  Google Scholar 

  4. Jakobsson GL, Stephansson O, Askling J, Jacobsson LT. Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study. Ann Rheum Dis 2016;75:1838–42

    Article  Google Scholar 

  5. Hench PS. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrarthrosis. Proc Staff Meet Mayo Clinic 1938;13:161–7

    Google Scholar 

  6. Jethwa H, Lam S, Smith C, Giles I. Does Inflammatory Arthritis Really Improve during Pregnancy? a Systematic Review and Meta-Analysis. Arthritis Rheumatol 2016; 68 (suppl 10). ACR abstract 1517

  7. Jawaheer D, Zhu JL, Nohr AE, Olsen J. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum 2011;63:1517–21

    Article  Google Scholar 

  8. Brouwer J, Hazes JM, Laven JS, Dolhain RJ. Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis 2015;74:1836–41

    Article  CAS  Google Scholar 

  9. Boots CE, Gustofson RL, Feinberg EC. Does methotrexate administration for ectopic pregnancy after in vitro fertilization impact ovarian reserve or ovarian responsiveness?. Fertil Steril 2013;100:1590–3

    Article  CAS  Google Scholar 

  10. Winger EE, Reed JL, Ashoush S, Ahuja S, El-Toukhy T, Taranissi M. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol 2009;61:113–20

    Article  CAS  Google Scholar 

  11. Flint J, Panchal S, Hurell A, van der Venne M, Gayed M, Schreiber K et al.; BSR and BHPR Standards, Guidelines and Audit Working Group. BSP and BHPR guideline on prescribing drugs in pregnancy and breastfeeding. Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford) 2016;55:1693–7

    Article  CAS  Google Scholar 

  12. Mitchell K, Kaul M, Clowse ME. The management of rheumatic diseases in Pregnancy. Scand J Reumatol 2010;39:99–108

    Article  CAS  Google Scholar 

  13. van den Brandt S, Zbinden A, Baeten D, Villiger PM, Ostensen M, Forger F. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther 2017;19:64–72

    Article  Google Scholar 

  14. Ostensen M, Brucato A, Carp H, Chambers C, Dolhain RJ, Doria A et al. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) 2011;50:657–64

    Article  Google Scholar 

  15. Desai RJ, Bateman BT, Huybrechts KF, Patorno E, Hernandez-Diaz S, Park Y et al. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ 2017;356:j895

    Article  Google Scholar 

  16. Reed SD, Vollan TA, Svec MA. Pregnancy outcomes in women with rheumatoid arthritis in Washington State. Matern Child Health J 2006;10:361–6

    Article  Google Scholar 

  17. Hyrich KL, Verstappen SM. Biologic therapies and pregnancy: the story so far. Rheumatology (Oxford) 2014;53:1377–85

    Article  CAS  Google Scholar 

  18. Berthelsen BG, Fjeldsoe-Nielsen H, Nielsen CT, Hellmuth E. Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breast-feeding. Rheumatology (Oxford) 2010;49:2225–7

    Article  CAS  Google Scholar 

  19. Weber-Schoendorfer C, Chambers C, Wacker E, Beghin D, Bernard N; Network of French Pharmacovigilance Centers et al. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis Rheum 2014;66:1101–10

    Article  CAS  Google Scholar 

  20. Mariette X, Forger F, Abraham B, Flynn AD, Molto A, Flipo RM et al. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, multicenter, pharmacokinetic study. Annual European Congress of Rheumatology in Madrid 2017; EULAR Abstract 17-1640

  21. Clowse ME, Wolf DC, Golembesky A, Shaugnessy L, De Cuyper D, Froger F. Characteristics and outcomes of prospectively-reported pregnancies exposed to certolizumab pegol from a safety database. ACR/AHRP Annual Meeting 2015; Poster Session C, Abstract Number: 2523

  22. Oliver A, Overton C. Diagnosis and management of miscarriage. Practitioner 2014;258:25–8

    PubMed  Google Scholar 

  23. Centers for Disease Control and Prevention (CDC). Update on overall prevalence of major birth defects. Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep 2008;57:1-5

  24. Polachek A, Li S, Polachek IS, Chandran V, Gladman D. Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Semin Arthritis Rheum 2017;46:740–5

    Article  Google Scholar 

  25. Clowse ME 2017 EULAR Poster SAT 046 und SAT 0119

  26. Hotham N, Hotham A. Drugs in breastfeeding. Aust Prescr 2015;38:156–9

    Article  Google Scholar 

  27. Derendorf H, Ruebsamen K, Clarke L, Schaeffler A, Kirwan JR. Pharmacokinetics of modified-release prednisone tablets in healthy subjects and patients with rheumatoid arthritis. J Clin Pharmacol 2013;53:326–33

    Article  CAS  Google Scholar 

  28. Guettrot-Imbert G, Costedoat-Chalumeau N, Tincani A. EULAR Textbook on Rheumatic Diseases, BMJ Publishing 2012

  29. Flint J, Panchal S, Hurrell A et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2016 Sep;55(9):1693-7. doi: 10.1093/rheumatology/kev404.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dieter Schöffel.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schöffel, D. Rheumakranke Frauen: Kinderwunsch ist heutzutage meist erfüllbar. Orthop. Rheuma 21, 34–40 (2018). https://doi.org/10.1007/s15002-018-1443-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15002-018-1443-0

Navigation